Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinib

Volume: 108, Issue: 5, Pages: 502 - 509
Published: Jul 23, 2021
Abstract
Background: Hemochrome parameters at the diagnosis of metastatic renal cell carcinoma (mRCC) and the development of macrocytosis during sunitinib therapy are considered prognostic. Objective: To evaluate the prognostic role of hematologic parameters and macrocytosis in mRCC treated with sunitinib. Methods: We analyzed clinical data of 100 patients with mRCC treated with sunitinib as first-line therapy in a retrospective multicenter study. We...
Paper Details
Title
Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinib
Published Date
Jul 23, 2021
Volume
108
Issue
5
Pages
502 - 509
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.